Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Collagen | 5 | 2019 | 147 | 1.490 |
Why?
|
| Fibroblasts | 9 | 2019 | 152 | 1.290 |
Why?
|
| Dupuytren Contracture | 3 | 2019 | 5 | 0.910 |
Why?
|
| Wound Healing | 3 | 2019 | 113 | 0.880 |
Why?
|
| Cytochalasin D | 1 | 2019 | 9 | 0.700 |
Why?
|
| Connective Tissue | 1 | 2019 | 4 | 0.690 |
Why?
|
| Chitosan | 1 | 2019 | 31 | 0.670 |
Why?
|
| Stress, Physiological | 1 | 2019 | 90 | 0.650 |
Why?
|
| Extracellular Matrix | 2 | 2019 | 111 | 0.650 |
Why?
|
| Myofibroblasts | 2 | 2019 | 22 | 0.630 |
Why?
|
| Cell Proliferation | 5 | 2019 | 762 | 0.620 |
Why?
|
| Cells, Cultured | 10 | 2019 | 968 | 0.580 |
Why?
|
| Keratinocytes | 3 | 2009 | 32 | 0.580 |
Why?
|
| Skin | 2 | 2009 | 139 | 0.530 |
Why?
|
| Cell Differentiation | 7 | 2016 | 394 | 0.500 |
Why?
|
| Epithelial Cells | 4 | 2014 | 240 | 0.400 |
Why?
|
| Bone Cements | 3 | 2016 | 8 | 0.390 |
Why?
|
| Biocompatible Materials | 3 | 2016 | 90 | 0.360 |
Why?
|
| Epithelium | 1 | 2009 | 39 | 0.340 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 59 | 0.330 |
Why?
|
| Bronchi | 2 | 2006 | 38 | 0.320 |
Why?
|
| Tomography, Optical Coherence | 2 | 2019 | 86 | 0.320 |
Why?
|
| Models, Biological | 2 | 2009 | 446 | 0.290 |
Why?
|
| Osteoblasts | 3 | 2016 | 35 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 439 | 0.280 |
Why?
|
| Titanium | 2 | 2016 | 34 | 0.270 |
Why?
|
| Respiratory Mucosa | 1 | 2006 | 51 | 0.260 |
Why?
|
| Tissue Engineering | 1 | 2006 | 152 | 0.230 |
Why?
|
| Skin Aging | 1 | 2004 | 8 | 0.230 |
Why?
|
| Lasers | 1 | 2004 | 67 | 0.220 |
Why?
|
| Cell Adhesion | 4 | 2016 | 132 | 0.210 |
Why?
|
| Cell Movement | 2 | 2019 | 352 | 0.200 |
Why?
|
| Humans | 15 | 2019 | 26749 | 0.200 |
Why?
|
| Transforming Growth Factor beta | 1 | 2000 | 77 | 0.170 |
Why?
|
| Microscopy | 1 | 2019 | 38 | 0.170 |
Why?
|
| Fibrosis | 1 | 2019 | 115 | 0.160 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 60 | 0.160 |
Why?
|
| Plasma Gases | 1 | 2016 | 4 | 0.140 |
Why?
|
| Dental Alloys | 1 | 2016 | 9 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 908 | 0.130 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 27 | 0.130 |
Why?
|
| Laser Therapy | 1 | 2016 | 30 | 0.130 |
Why?
|
| Polymethyl Methacrylate | 1 | 2014 | 2 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2006 | 114 | 0.120 |
Why?
|
| Biological Assay | 1 | 2014 | 35 | 0.120 |
Why?
|
| Breast | 1 | 2014 | 51 | 0.110 |
Why?
|
| Muscle, Smooth | 2 | 2006 | 40 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 453 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2009 | 161 | 0.100 |
Why?
|
| Isotonic Contraction | 1 | 1992 | 6 | 0.100 |
Why?
|
| Cytoskeleton | 1 | 1992 | 40 | 0.100 |
Why?
|
| Materials Testing | 3 | 2016 | 86 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2014 | 273 | 0.090 |
Why?
|
| Cadherins | 1 | 2009 | 24 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 180 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2004 | 239 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 128 | 0.080 |
Why?
|
| Disease Progression | 1 | 2009 | 450 | 0.070 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2004 | 19 | 0.070 |
Why?
|
| Telomere | 2 | 2004 | 28 | 0.070 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2006 | 4 | 0.070 |
Why?
|
| Granulation Tissue | 1 | 2006 | 7 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2006 | 247 | 0.070 |
Why?
|
| Cell Shape | 1 | 2006 | 15 | 0.070 |
Why?
|
| Surface Properties | 2 | 2016 | 132 | 0.070 |
Why?
|
| Oncogenes | 1 | 2006 | 34 | 0.070 |
Why?
|
| Hardness | 2 | 2016 | 6 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 139 | 0.060 |
Why?
|
| Tensile Strength | 2 | 2016 | 32 | 0.060 |
Why?
|
| Isometric Contraction | 1 | 2006 | 117 | 0.060 |
Why?
|
| Cell Compartmentation | 1 | 2004 | 5 | 0.060 |
Why?
|
| Basement Membrane | 1 | 2004 | 6 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2004 | 11 | 0.060 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2004 | 14 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 276 | 0.060 |
Why?
|
| Biomarkers | 1 | 2006 | 731 | 0.050 |
Why?
|
| Lung | 1 | 2004 | 349 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 339 | 0.050 |
Why?
|
| Muscle Contraction | 2 | 1999 | 161 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 748 | 0.050 |
Why?
|
| Rats | 3 | 2016 | 1539 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2004 | 841 | 0.040 |
Why?
|
| Telomerase | 3 | 2006 | 37 | 0.040 |
Why?
|
| Actins | 1 | 2000 | 93 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 1999 | 118 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 587 | 0.040 |
Why?
|
| Cell Culture Techniques | 2 | 2014 | 115 | 0.040 |
Why?
|
| Animals | 4 | 2016 | 9927 | 0.040 |
Why?
|
| Alloys | 1 | 2016 | 5 | 0.030 |
Why?
|
| Cell Growth Processes | 2 | 2006 | 18 | 0.030 |
Why?
|
| Cell Line | 1 | 2016 | 671 | 0.030 |
Why?
|
| Transfection | 2 | 2006 | 312 | 0.030 |
Why?
|
| Ploidies | 1 | 2014 | 6 | 0.030 |
Why?
|
| Compressive Strength | 1 | 2014 | 8 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 8 | 0.030 |
Why?
|
| Adhesiveness | 1 | 2014 | 6 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2014 | 22 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 55 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2004 | 9 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2004 | 15 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2006 | 239 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2004 | 97 | 0.030 |
Why?
|
| Temperature | 1 | 2014 | 207 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1992 | 10 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1992 | 94 | 0.030 |
Why?
|
| Serum Albumin | 1 | 1992 | 35 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 663 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2006 | 542 | 0.020 |
Why?
|
| Aged | 2 | 2014 | 5154 | 0.020 |
Why?
|
| Calcium | 2 | 2003 | 231 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 482 | 0.020 |
Why?
|
| Female | 3 | 2014 | 14405 | 0.020 |
Why?
|
| Adult | 2 | 2014 | 7352 | 0.020 |
Why?
|
| Mice | 1 | 2016 | 4393 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 2573 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2006 | 10 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2006 | 12 | 0.020 |
Why?
|
| Genes, erbB-1 | 1 | 2006 | 2 | 0.020 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2006 | 3 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2006 | 7 | 0.020 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2006 | 10 | 0.020 |
Why?
|
| Genes, ras | 1 | 2006 | 12 | 0.020 |
Why?
|
| Amides | 1 | 2006 | 18 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2006 | 14 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2006 | 26 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2006 | 23 | 0.020 |
Why?
|
| Quinazolines | 1 | 2006 | 31 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2006 | 37 | 0.020 |
Why?
|
| RNA Interference | 1 | 2006 | 135 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2006 | 96 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2006 | 86 | 0.020 |
Why?
|
| Pyridines | 1 | 2006 | 99 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 145 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 142 | 0.020 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2004 | 7 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2004 | 37 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2004 | 16 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2004 | 73 | 0.020 |
Why?
|
| Karyotyping | 1 | 2004 | 24 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 41 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 558 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 49 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 122 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 115 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 113 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2004 | 114 | 0.010 |
Why?
|
| Cyclin D | 1 | 2003 | 2 | 0.010 |
Why?
|
| Cyclins | 1 | 2003 | 8 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2003 | 36 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2003 | 29 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 6792 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 153 | 0.010 |
Why?
|
| DNA Replication | 1 | 2003 | 49 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 197 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 439 | 0.010 |
Why?
|
| Cellular Senescence | 1 | 2003 | 121 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2004 | 511 | 0.010 |
Why?
|
| Ionophores | 1 | 1999 | 6 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2006 | 1335 | 0.010 |
Why?
|
| Lysophospholipids | 1 | 1999 | 48 | 0.010 |
Why?
|
| Fibronectins | 1 | 1999 | 28 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 1999 | 42 | 0.010 |
Why?
|
| Male | 2 | 2006 | 12826 | 0.010 |
Why?
|